Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
US7229775B2 · kind B2 · utility
5Cited by
21References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2004 |
| Grant date | Jun 12, 2007 |
| Priority date | — |
| Expiry date | Sep 26, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/104165
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Immunoassays for malondialdehyde-modified low density lipoprotein (MDA-modified LDL) and oxidized low density lipoprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control) are disclosed. MDA-modified LDL and OxLDL are implicated in atherosclerosis and its etiology.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.